MENU
+Compare
NKTX
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$2.37
Change
+$0.17 (+7.73%)
Capitalization
167.25M

NKTX Nkarta Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for NKTX with price predictions
Dec 20, 2024

NKTX's RSI Indicator climbs out of oversold territory

The RSI Indicator for NKTX moved out of oversold territory on December 19, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 45 similar instances when the indicator left oversold territory. In of the 45 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for NKTX just turned positive on December 20, 2024. Looking at past instances where NKTX's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NKTX advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

NKTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NKTX as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NKTX entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.388) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). NKTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NKTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NKTX is expected to report earnings to rise 1.92% to -39 cents per share on March 20

Nkarta NKTX Stock Earnings Reports
Q4'24
Est.
$-0.40
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.13
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.01
The last earnings report on November 07 showed earnings per share of -38 cents, missing the estimate of -37 cents. With 1.92M shares outstanding, the current market capitalization sits at 167.25M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AOFCX17.130.30
+1.78%
Alger Small Cap Focus C
ARTJX17.170.17
+1.00%
Artisan International Small-Mid Investor
SBIAX9.880.03
+0.30%
Sterling Capital Behavioral Intl Eq A
VDMRX8.590.01
+0.12%
Virtus KAR Developing Markets R6
JSJFX17.03N/A
+0.01%
JHancock Small Cap Dynamic Growth R6

NKTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with PGEN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+7.73%
PGEN - NKTX
50%
Loosely correlated
+5.07%
FATE - NKTX
49%
Loosely correlated
+1.20%
IPSC - NKTX
48%
Loosely correlated
+4.76%
BCRX - NKTX
47%
Loosely correlated
+2.44%
ALLO - NKTX
46%
Loosely correlated
+1.63%
More